A novel PIK3 inhibitor combined with fulvestrant nearly doubled progression- free survival (PFS) in PIK3CA-mutated breast cancer.
Medscape Medical News …read more
A novel PIK3 inhibitor combined with fulvestrant nearly doubled progression- free survival (PFS) in PIK3CA-mutated breast cancer.
Medscape Medical News …read more